Showing 2,261 - 2,280 results of 6,418 for search '"Stem cell', query time: 0.13s Refine Results
  1. 2261
  2. 2262
  3. 2263
  4. 2264
  5. 2265
  6. 2266
  7. 2267
  8. 2268

    Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience by Wei Sheng Joshua Loke, Jean Rachel Catapia, Chay Lee Low, Francesca Lim, Jeffrey Quek, Hein Than, Yeow Tee Goh, Yeh Ching Linn, Colin Phipps Diong, Aloysius Ho, William Hwang, Chung Cheng Jordan Hwang, Aditi Ghosh, Liang Pui Koh, Lip Koon Tan, Joanne Lee, Li Mei Michelle Poon, Cheng Kiat Lawrence Ng

    Published 2025-01-01
    “… Introduction: Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a curative option for relapse/refractory (R/R) lymphomas that have failed autologous transplantation or for high-risk lymphomas in the upfront setting. …”
    Get full text
    Article
  9. 2269

    Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis by Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith

    Published 2017-05-01
    “…Here, we describe a case of AVWS occurring after autologous stem cell transplantation (ASCT). Interestingly, AVWS developed after bortezomib-based induction and conditioning regimens. …”
    Get full text
    Article
  10. 2270

    Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement by Stephan Zaenker, Stefan Schweyer, Justin Hasenkamp, Lorenz Truemper, Gerald Wulf

    Published 2011-01-01
    “…At year six after transplantation, the patient experienced disease progression by meningeosis leukaemia to which she succumbed despite intrathecal chemotherapy. Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control.…”
    Get full text
    Article
  11. 2271

    Tumor Necrosis Factor Receptor 1 Is Required for Human Umbilical Cord–Derived Mesenchymal Stem Cell–Mediated Rheumatoid Arthritis Therapy by Guangyang Liu, Herui Wang, Chenliang Zhang, Xin Li, Yi Mi, Yaoyao Chen, Liqiang Xu, Li Miao, Haomiao Long, Yongjun Liu

    Published 2025-01-01
    “…Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have shown potential in alleviating the symptoms of RA. …”
    Get full text
    Article
  12. 2272

    Impact of Magnetic Labeling on Human and Mouse Stem Cells and Their Long-Term Magnetic Resonance Tracking in a Rat Model of Parkinson Disease by Albrecht Stroh, Johannes Boltze, Katharina Sieland, Katharina Hild, Cindy Gutzeit, Tobias Jung, Jenny Kressel, Susann Hau, Doreen Reich, Tilman Grune, Claus Zimmer

    Published 2009-05-01
    “…Magnetic resonance imaging (MRI) of magnetically labeled stem cells has become a valuable tool in the understanding and evaluation of experimental stem cell–based therapies of degenerative central nervous system disorders. …”
    Get full text
    Article
  13. 2273
  14. 2274
  15. 2275

    LIF Promotes Sec15b‐Mediated STAT3 Exosome Secretion to Maintain Stem Cell Pluripotency in Mouse Embryonic Development by Li Xu, Jinjun Ji, Lingbo Wang, Jieli Pan, Mingzhe Xiao, Chenxi Zhang, Yihong Gan, Guanqun Xie, Mingdian Tan, Xinchang Wang, Chengping Wen, Yongsheng Fan, Y. Eugene Chin

    Published 2024-12-01
    “…Abstract LIF maintains self‐renewal growth in mouse embryonic stem cells (mESC) by activating STAT3, which translocates into nucleus for pluripotent gene induction. …”
    Get full text
    Article
  16. 2276
  17. 2277
  18. 2278
  19. 2279
  20. 2280